Publications in collaboration with researchers from Hospital Universitario de Valladolid (20)

2024

  1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

  2. Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study

    Neurologia

2022

  1. Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology

    Neurologia, Vol. 37, Núm. 1, pp. 61-72

  2. Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain

    Neurologia

2021

  1. Delayed Neurological Improvement After Full Endovascular Reperfusion in Acute Anterior Circulation Ischemic Stroke

    Stroke, Vol. 52, Núm. 7, pp. 2210-2217

  2. Impact of Mediterranean Diet prior to Stroke on the Prognosis of Patients Undergoing Endovascular Treatment

    Cerebrovascular Diseases, Vol. 50, Núm. 3, pp. 303-309

  3. Recommendations of the Spanish Society of Neurology for the prevention of stroke. Interventions on lifestyle and air pollution

    Neurologia, Vol. 36, Núm. 5, pp. 377-387

  4. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  5. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

  6. Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group

    Neurologia, Vol. 36, Núm. 6, pp. 462-471

  7. Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology

    Neurologia, Vol. 36, Núm. 4, pp. 305-323

  8. Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease

    Neurologia, Vol. 36, Núm. 1, pp. 1-8

2020

  1. Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain

    European Journal of Neurology, Vol. 27, Núm. 12, pp. 2491-2498

  2. Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain

    International Journal of Stroke, Vol. 15, Núm. 7, pp. 755-762

  3. Oral Anticoagulation and Risk of Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Mechanical Thrombectomy: Data From the Nordictus Registry

    Frontiers in Neurology, Vol. 11

  4. Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey

    Neurologia, Vol. 35, Núm. 4, pp. 252-257

2019

  1. Relevance of collaterals for the success of neuroprotective therapies in acute ischemic stroke: Insights from the randomized URICO-ICTUS Trial

    Cerebrovascular Diseases, Vol. 47, Núm. 3-4, pp. 171-177

2017

  1. GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke

    Stroke, Vol. 48, Núm. 5, pp. 1147-1153

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

  2. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): A randomised, double-blind phase 2b/3 trial

    The Lancet Neurology, Vol. 13, Núm. 5, pp. 453-460